It protects the lung tissue from oxidative stress, and an altered GLRX3 is known to affect idiopathic pulmonary fibrosis, asthma, and COPD in rodent models or cell-based studies [23]. This evidence concerns the gene GLRX3 and pulmonary fibrosis.